Vanderbilt asthma laiv
Ended Awarded Last action
- Contract number
- HHSD2002012504300004
- Awardee
-
The Vanderbilt University UEI DWH7MSXKA2A8
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $595,374
Award facts
- Opportunity
-
- 2012N14296 Solicitation number
- Contract value 56% obligated
-
- $595,374.00 Current, with exercised options
- $1,072,649.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621399 Offices of All Other Miscellaneous Health Practitioners
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Other
- Place of performance
- Nashville, TN 37240, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $41,322 | |
| Supplemental Agreement for work within scope | $161,384 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $392,668 |
About this award
This federal contract award, valued at $1,072,649.00, was issued by the Centers for Disease Control and Prevention (CDC) to The Vanderbilt University, a leading private research institution. The contract is a delivery order under the Clinical Immunization Safety Assessment (CISA) indefinite delivery vehicle, which supports the CDC's efforts to conduct research and analysis related to vaccine safety. The award does not have a set-aside designation, reflecting Vanderbilt's status as a large educational institution. As the prime contractor, Vanderbilt will provide services related to the evaluation of vaccine safety and clinical outcomes in Nashville, Tennessee. The university has significant expertise in medical research and healthcare analysis, which aligns well with the objectives of this contract. Vanderbilt has also received various federal grants and contracts from agencies like the National Institutes of Health, the National Science Foundation, and the Department of Veterans Affairs, demonstrating its capabilities in addressing national priorities through collaborative research and development.
Quick answers
Who was awarded contract HHSD2002012504300004?
HHSD2002012504300004 was awarded to The Vanderbilt University by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 30, 2015.
How much is contract HHSD2002012504300004 worth?
The government has obligated $595,374 on HHSD2002012504300004. Its potential value, with all options, is $1,072,649.
Is contract HHSD2002012504300004 an order under another contract?
Yes. HHSD2002012504300004 is a delivery order under HHSD200201250430I, an indefinite delivery contract, on Clinical Immunization Safety Assessment (CISA).
Was contract HHSD2002012504300004 competed?
The extent of competition for HHSD2002012504300004 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award